Athlete Screening for Occult Cardiac Disease. No Risk, No Fun?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 10, 2008, Pages 1040-1041

  Faber, Lothar ^a   van Buuren, Frank ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; CARDIOVASCULAR RISK; EDITORIAL; ELECTROCARDIOGRAM; EXERCISE; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MASS SCREENING; PRIORITY JOURNAL; SUDDEN DEATH;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART DISEASES; HUMANS; MASS SCREENING; SPORTS;

EID: 39849093000     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.11.047     Document Type: Editorial

References (11)

1. Maron B.J., and Pellicia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 114 (2006) 1633-1644
2. Corrado D., Basso C., Schiavon M., and Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339 (1998) 364-369
3. Corrado D., Basso C., Pavei A., Michieli P., Schiavon M., and Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296 (2006) 1593-1601
4. Maron B.J., and Zipes D.P. 36th Bethesda conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45 (2005) 1312-1375
5. Pelliccia A., Fagard R., Bjørnstad H.H., et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J 14 (2005) 1422-1445
6. Corrado D., Pelliccia A., Bjørnstad H.H., et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 5 (2005) 516-524
7. Basavarajaiah S., Wilson M., Whyte G., Shah A., McKenna W., and Sharma S. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol 51 (2008) 1033-1039
8. Sharma S., Maron B.J., Whyte G., Firoozi S., Elliott P.M., and McKenna W.J. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 1431-1436
9. Whyte G.P., Sheppard M., George K., et al. Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause?. Br J Sports Med (2008) (Epub ahead of print)
10. Heidbüchel H., Hoogsteen J., Fagard R., et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias: role of an electrophysiologic study in risk stratification. Eur Heart J 24 (2003) 1473-1480
11. D'Andrea A., D'Andrea L., Caso P., Scherillo M., Zeppili P., and Calabro R. The usefulness of doppler myocardial imaging in the study of the athlete's heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy. Echocardiography 23 (2006) 149-157